BIGNARDI, GAETANO
 Distribuzione geografica
Continente #
EU - Europa 5.176
Totale 5.176
Nazione #
IT - Italia 5.176
Totale 5.176
Città #
Genova 3.925
Rapallo 621
Genoa 598
Bordighera 17
Vado Ligure 15
Totale 5.176
Nome #
Study of the interaction of dithranol with heptakis(2,3,6-tri-O-methyl)-b-cyclodextrin in solution and in the solid state 137
Complex extemporaneous preparations: stability study of a formulation containing diethylpropion hydrochloride in hard capsules 125
An example of application of a mixture design with constraints to a pharmaceutical formulation 125
Study of retinoic acid polymorphism 119
STABILITY INDICATING HPLC ASSAY FOR RETINOIC ACID IN HARD GELATINE CAPSULES CONTAINING LACTOSE AND AS BULK DRUG SUBSTANCE 117
Development and characterization of a buccoadhesive dosage form of oxycodone hydrochloride 117
Optimization of cross-linked high amylose starch microspheres containing 5-fluorouracil 113
Median-based robust regression methods in prediction of drug stability 113
Poloxamer 407 as a solubilising agent for tolfenamic acid and as a base for a gel formulation 112
Preparation and evaluation of a chitosan salt–poloxamer 407 based matrix for buccal drug delivery 111
Development, characterization and preliminary clinical evaluation of mucoadhesive vaginal gels containing chlorhexidine digluconate 109
Identification of degradation products of Ibuprofen arising from oxidative and thermal treatments 105
Stability study of hard gelatin capsules containing retinoic acid 104
A Method for the production of bioadhesive compact matrices (European Patent) 104
A new carrier for cisplatin: nanoparticles deriving from the interaction between N-trimethyl glycol chitosan and poly-L-glutamate 101
Optimization of cross-linked high amylose starch microspheres containing 5-fluorouracil 96
Preparation and evaluation of nanoparticles made of chitosan or N-trimethyl chitosan and a cisplatin-alginate complex 95
A METHOD FOR THE PRODUCTION OF BIOADHESIVE COMPACT MATRICES (US Patent) 95
Cisplatin delivery: a study on a cisplatin-hyaluronate complex and nanoparticles formed by its interaction with N-trimethyl chitosan 94
A method for the production of bioadhesive compact matrices (Japanese Patent) 94
Characterisation and in vitro evaluation of biological activity of retinoic acid complexes with some bile salts 92
Identificazione di nuovi prodotti di degradazione dell'ibuprofene. 91
A Chitosan-Poloxamer 407 Matrix for Buccal Drug Delivery. 91
A METHOD FOR THE PRODUCTION OF BIOADHESIVE COMPACT MATRICES THAT CAN BE USED EITHER AS SUCH OR FOR THE PROLONGED RELEASE OF ACTIVE SUBSTANCES, AND COMPACT MATRICES THUS OBTAINED 91
Development and in vitro evaluation of buccoadhesive tablets using a new model substrate for bioadhesion measures: the eggshell membrane 91
Cycloaddition of dichloroketene to N,N-disubstituted 3-aminomethylene-5-hydroxy- 2,2-dimethyl-7-pentyl-4-chromanone: synthesis of 2H,5H-pyrano[3,2-c][1] benzopyran derivatives 90
Metodo di produzione di matrici compatte bioadesive impiegabili come tali o per il rilascio controllato di sostanze attive e matrici compatte così ottenute. 89
Chitosan-Alginate Nanoparticles Containing Cisplatin Complexed With Alginate 87
Preparation and evaluation of N-trimethyl chitosan/alginate nanoparticles containing cisplatin complexed with alginate 85
PROCEDE POUR LA FABRICATION DE MATRICES COMPACTES BIOADHESIVES QUI PEUVENT ETRE UTILISEES SOIT EN TANT QUE TELLES, SOIT POUR LA LIBERATION PROLONGEE DE SUBSTANCES ACTIVES ET MATRICES COMPACTES AINSI OBTENUES A METHOD FOR THE PRODUCTION OF BIOADHESIVE COMPACT MATRICES THAT CAN BE USED EITHER AS SUCH OR FOR THE PROLONGED RELEASE OF ACTIVE SUBSTANCES, AND COMPACT MATRICES THUS OBTAINED (Canadian Patent) 85
Hemolytic Action and Surface Activity of Triterpene Saponins from Anchusa officinalis L. 83
Solubilization study of retinoic acid employing some bile salts 83
Modification of Drug Release from Tablets Produced By direct compression 82
Serum, urine and peritoneal fluid levels of 5-FU following intraperitoneal administration. 80
Nanoparticles Formed by Interaction of Poly-L-Lysine or Chitosan With Polycarboxylic Polymers Complexed with Cisplatin 79
A METHOD FOR THE PRODUCTION OF BIOADHESIVE COMPACT MATRICES (China Patent) 79
A Method for the production of bioadhesive compact matrices (Russian Patent) 79
Preformulative study of liposomes containing retinoic acid 78
Applicazione del metodo di regressione robusta MBWR nella previsione di shelf life: stabilità di capsule contenenti acido retinoico. 75
A Method for the production of bioadhesive compact matrices 75
Aspetti preliminari di uno studio preformulativo riguardante l'acido retinoico. 70
Mucoadesive polymeric films and reservoir devices for transmucosal drug delivery. 70
FUNCTIONAL INTERACTIONS BETWEEN ALL TRANS RETINOIC ACID AND BILE SALTS ON CELL PROLIFERATION. 65
Rivestimento con film polimerici di forme di dosaggio buccoadesive 63
Complessazione dell’acido retinoico mediante sali di acidi biliari: caratterizzazione chimico-fisica e valutazione dell’efficacia antiproliferativa su colture cellulari 63
Mucoadhesive polymeric films and reservoir devices for transmucosal drug delivery 63
Formulazione bioadesiva per somministrazione boccale di Ossicodone cloridrato 61
"Valutazione in vitro della bioadesività di forme di dosaggio boccali" 60
Piroxicam loaded spray dried microspheres as carrier in controlled drug delivery. 60
Studio di solubilizzazione dell’acido retinoico mediante l’impiego di alcuni sali biliari 58
Protein loaded nanoparticles made of cross-linked high amylose starch and N-trimethyl glicol chitosan 58
Sviluppo di due forme farmaceutiche solide contenenti la forma triclina dell'acido retinoico. 57
Interazione fra Antralina e ciclodestrine 56
Interazione fra acido tolfenamico e poloxamero 407 e studio di rilascio da geli 55
Tolfenamic acid gels based on poloxamer 407. Evaluation by a mixture experimental design 55
Polyphenolische Verbindungen aus Quercus ilex L. 54
Studio di caratterizzazione del polimorfismo dell’acido retinoico. 53
Formulation and in vitro Evaluation of Bioadhesive Films for Buccal Drug administration. 53
Synthesis and Antitumor Activity of a New Cis-Diammineplatinum(II) Complex Containing Procaine Hydrocloride 52
Nanoparticelle: loro proprietà e prospettive per l'uso in medicina 49
Studio preliminare di modifica di rilascio del diltiazem da compresse ottenute per compressione diretta. 47
Stability indicating TLC for retinoic acid in hard gelatine capsules containing lactose and as bulk drug substance 44
INVESTIGATIONAL STUDY ON AN INNOVATIVE MATRIX FOR EXTENDED DRUG RELEASE OBTAINED BY SUBMITTING TO A THERMAL TREATMENT TABLETS PRODUCED BY DIRECT COMPRESSION 44
Preparation and characterization of cross-linked high amylose starch poloxamer P407 matrices 38
Totale 5.219
Categoria #
all - tutte 14.011
article - articoli 6.011
book - libri 0
conference - conferenze 5.931
curatela - curatele 0
other - altro 0
patent - brevetti 2.069
selected - selezionate 0
volume - volumi 0
Totale 28.022


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/20201.262 0 19 78 52 98 149 194 49 90 272 204 57
2020/2021208 11 10 15 10 6 29 8 10 31 13 36 29
2021/2022717 9 77 59 96 15 27 48 186 28 65 16 91
2022/2023760 84 48 7 111 115 151 4 52 127 6 48 7
2023/2024426 19 51 7 62 26 146 26 18 17 3 21 30
2024/202565 54 11 0 0 0 0 0 0 0 0 0 0
Totale 5.219